Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Study on how medicines affect breastfeeding and infant exposure through human milk

Official title: Clinical Lactation Study on the Exposure to Medicines Via Human Milk: an Umbrella Study Protocol

Run by Universitaire Ziekenhuizen KU Leuven · NCT06042803 · Data updated 2026-11-12

This study is trying to see how different medicines affect breast milk and how much of those medicines babies might get when breastfeeding.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment30 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven, Vlaams-Brabant)
StatusRecruiting
StartedFebruary 1, 2023
Main results expectedDecember 2026
Study endsFebruary 2027
Registry record updatedFebruary 27, 2025
Trial IDNCT06042803 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include breastfeeding women aged 18 and older who are currently using medications and willing to participate in milk and blood sample collection.

Probably not a fit

Patients who are not breastfeeding, those under 18 years of age, or mothers of twins may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to determine the concentration of various medicines in human milk during maternal medication intake and to estimate the exposure of breastfed infants to these medicines. Participants, including breastfeeding mothers and their infants, will complete questionnaires about their medical history, track medication intake for three days, and collect milk samples over a 24-hour period. Additionally, mothers may provide blood samples, and consent for a blood sample from the infant may also be requested. The study seeks to fill the information gap regarding the safety of medications during lactation, which is crucial for informed decision-making about breastfeeding and pharmacotherapy.

Why it matters

Potential benefit: If successful, this study could provide critical data to support safe medication use during breastfeeding, potentially improving adherence to both breastfeeding and necessary pharmacological treatments.

How similar studies have gone: While there is limited data on this specific approach, the study addresses a significant gap in existing literature regarding medication safety during lactation, suggesting a novel and necessary investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For breastfeeding women

  * Maternal age: ≥ 18 year
  * Currently exclusively or partially breastfeeding (/expressing milk) at the time of milk sampling
  * Using medicines for any indication, with at least 5 half-lives of the medicine taken
  * Willing to express and collect human milk
  * Signed informed consent to participate and for processing their personal data
* For infants

  * Gestational age at birth: ≥24 weeks
  * Parental signed informed consent to participate and for processing their personal data

Exclusion Criteria:

* Maternal age \<18 years
* Mother of twins
* Not meeting the inclusion criteria

Where it's running

  • Universitaire Ziekenhuizen KU Leuven
    Leuven, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

  • Principal investigator: Anne Smits, MD PhD — Universitaire Ziekenhuizen KU Leuven
  • Study coordinator: Anne Smits, MD, PhD
  • Email: anne.smits@uzleuven.be
  • Phone: +3216343565

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.